Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Injectable Drug Delivery Market Data Survey Report 2025

  • HEY1469690
  • 112 Pages
  • August 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
Summary

Injectable drug delivery is defined as administration of a drug or drugs directly into patient’s blood circulationthrough a delivery device. It is considered as the most common and effective route of administration of most therapeutic agents to achieve the desired quick response. The injectable route of drug administration is expected to continue to be an important delivery system. This has been attributed to reasons that injectable drug delivery system allows administration of drugs with poor oral bioavailability, delivery of the drug at the site of action, targeted drug delivery system. Reduction in the number of injection is achieved by various technologies such as controlled release, targeted delivery and needle free delivery thus overcoming the problems associated with conventional injectable drug delivery. This has also helped in improving quality of therapy. Injectable drug delivery has also proved beneficial in many cases such as unconsciousness, emergency conditions and nausea, due to rapid onset of action. The basic requirement for injectable drug delivery is that it should be pyrogen free, sterile and isotonic.

The global Injectable Drug Delivery market will reach xxx Million USD in 2017 with CAGR xx% from 2018-2025. The main contents of the report including:

Global market size and forecast

Regional market size, production data and export & import

Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)

Average market price by SUK

Major applications

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:

Becton

Dickinson and Company

Baxter International

Gerresheimer

Pfizer

Schott

Sandoz

Teva Pharmaceutical Industries

Eli Lilly and Company

Antares Pharma

Eli Lilly & Company

Hospira

Novo Nordik

Sanofi

Terumo Corporation

Unilife Corporation

Zogenix

Scandinavian Health

Major applications as follows:

Aesthetics

Autoimmune Diseases

Hormonal Disorders

Infectious Diseases

Oncology

Pain Management

Regional market size, production data and export & import:

Asia-Pacific

North America

Europe

South America

Middle East & Africa

Table of Contents

1 Global Market Overview

1.1 Scope of Statistics

1.1.1 Scope of Products

1.1.2 Scope of Manufacturers

1.1.3 Scope of Application

1.1.4 Scope of Regions/Countries

1.2 Global Market Size

2 Regional Market

2.1 Regional Production

2.2 Regional Demand

2.3 Regional Trade

3 Key Manufacturers

3.1 Becton

3.1.2 Company Information

3.1.2 Product Specifications

3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.2 Dickinson and Company

3.2.1 Company Information

3.2.2 Product Specifications

3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.3 Baxter International

3.3.1 Company Information

3.3.2 Product Specifications

3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.4 Gerresheimer

3.4.1 Company Information

3.4.2 Product Specifications

3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.5 Pfizer

3.5.1 Company Information

3.5.2 Product Specifications

3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.6 Schott

3.6.1 Company Information

3.6.2 Product Specifications

3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.7 Sandoz

3.7.1 Company Information

3.7.2 Product Specifications

3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.8 Teva Pharmaceutical Industries

3.8.1 Company Information

3.8.2 Product Specifications

3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.9 Eli Lilly and Company

3.9.1 Company Information

3.9.2 Product Specifications

3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.10 Antares Pharma

3.10.1 Company Information

3.10.2 Product Specifications

3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.11 Eli Lilly & Company

3.12 Hospira

3.13 Novo Nordik

3.14 Sanofi

3.15 Terumo Corporation

3.16 Unilife Corporation

3.17 Zogenix

3.18 Scandinavian Health

4 Major Application

4.1 Aesthetics

4.1.1 Overview

4.1.2 Aesthetics Market Size and Forecast

4.2 Autoimmune Diseases

4.2.1 Overview

4.2.2 Autoimmune Diseases Market Size and Forecast

4.3 Hormonal Disorders

4.3.1 Overview

4.3.2 Hormonal Disorders Market Size and Forecast

4.4 Infectious Diseases

4.4.1 Overview

4.4.2 Infectious Diseases Market Size and Forecast

4.5 Oncology

4.5.1 Overview

4.5.2 Oncology Market Size and Forecast

4.6 Pain Management

4.6.1 Overview

4.6.2 Pain Management Market Size and Forecast

5 Market Price

5.1 Overview

5.2 Price by SUK

6 Conclusion


List Of Tables
Tab Regional Production 2011-2017 (Value)

Tab Regional Production 2011-2017 (Volume)

Tab Regional Demand and CAGR 2011-2017 (Value)

Tab Regional Demand and CAGR 2011-2017 (Volume)

Tab Regional Demand Forecast and CAGR 2018-2025 (Value)

Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)

Tab Regional Export 2011-2017 (Value)

Tab Regional Export 2011-2017 (Volume)

Tab Regional Import 2011-2017 (Value)

Tab Regional Import 2011-2017 (Volume)

Tab Sales Revenue, Volume, Price, Cost and Margin of Becton

Tab Sales Revenue, Volume, Price, Cost and Margin of Dickinson and Company

Tab Sales Revenue, Volume, Price, Cost and Margin of Baxter International

Tab Sales Revenue, Volume, Price, Cost and Margin of Gerresheimer

Tab Sales Revenue, Volume, Price, Cost and Margin of Pfizer

Tab Sales Revenue, Volume, Price, Cost and Margin of Schott

Tab Sales Revenue, Volume, Price, Cost and Margin of Sandoz

Tab Sales Revenue, Volume, Price, Cost and Margin of Teva Pharmaceutical Industries

Tab Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly and Company

Tab Sales Revenue, Volume, Price, Cost and Margin of Antares Pharma

Tab Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly & Company

Tab Sales Revenue, Volume, Price, Cost and Margin of Hospira

Tab Sales Revenue, Volume, Price, Cost and Margin of Novo Nordik

Tab Sales Revenue, Volume, Price, Cost and Margin of Sanofi

Tab Sales Revenue, Volume, Price, Cost and Margin of Terumo Corporation

Tab Sales Revenue, Volume, Price, Cost and Margin of Unilife Corporation

Tab Sales Revenue, Volume, Price, Cost and Margin of Zogenix

Tab Sales Revenue, Volume, Price, Cost and Margin of Scandinavian Health

Tab Market Price by Region

Tab Market Price by Manufacturers

Tab Market Price by Application

Tab Price by SUK (Popular Goods on the Market)
List Of Figures
Fig Global Injectable Drug Delivery Market Size and CAGR 2011-2017 (Value)

Fig Global Injectable Drug Delivery Market Size and CAGR 2011-2017 (Volume)

Fig Global Injectable Drug Delivery Market Forecast and CAGR 2018-2025 (Value)

Fig Global Injectable Drug Delivery Market Forecast and CAGR 2018-2025 (Volume)

Fig Aesthetics Market Size and CAGR 2011-2017 (Value)

Fig Aesthetics Market Size and CAGR 2011-2017 (Volume)

Fig Aesthetics Market Forecast and CAGR 2018-2025 (Value)

Fig Aesthetics Market Forecast and CAGR 2018-2025 (Volume)

Fig Autoimmune Diseases Market Size and CAGR 2011-2017 (Value)

Fig Autoimmune Diseases Market Size and CAGR 2011-2017 (Volume)

Fig Autoimmune Diseases Market Forecast and CAGR 2018-2025 (Value)

Fig Autoimmune Diseases Market Forecast and CAGR 2018-2025 (Volume)

Fig Hormonal Disorders Market Size and CAGR 2011-2017 (Value)

Fig Hormonal Disorders Market Size and CAGR 2011-2017 (Volume)

Fig Hormonal Disorders Market Forecast and CAGR 2018-2025 (Value)

Fig Hormonal Disorders Market Forecast and CAGR 2018-2025 (Volume)

Fig Infectious Diseases Market Size and CAGR 2011-2017 (Value)

Fig Infectious Diseases Market Size and CAGR 2011-2017 (Volume)

Fig Infectious Diseases Market Forecast and CAGR 2018-2025 (Value)

Fig Infectious Diseases Market Forecast and CAGR 2018-2025 (Volume)

Fig Oncology Market Size and CAGR 2011-2017 (Value)

Fig Oncology Market Size and CAGR 2011-2017 (Volume)

Fig Oncology Market Forecast and CAGR 2018-2025 (Value)

Fig Oncology Market Forecast and CAGR 2018-2025 (Volume)

Fig Pain Management Market Size and CAGR 2011-2017 (Value)

Fig Pain Management Market Size and CAGR 2011-2017 (Volume)

Fig Pain Management Market Forecast and CAGR 2018-2025 (Value)

Fig Pain Management Market Forecast and CAGR 2018-2025 (Volume)

Fig Global Market Price 2011-2017

Fig Global Market Price 2018-2025

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390